Comparison of Patients' Postpartum Recovery Using ObsQoR-10 Score in Pregnant Women in Vaginal Delivery With and Without Neuraxial Labor Analgesia

Last updated: March 16, 2024
Sponsor: Ataturk University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pain

Treatment

labor with neuraxial labor analgesia

labour without noroaxial labor analgesia

Clinical Study ID

NCT06325475
B.30.2.ATA.0.01.00/530
  • Ages 18-40
  • Female
  • Accepts Healthy Volunteers

Study Summary

The aim of this study was to compare the postpartum recovery of pregnant women who had vaginal delivery with and without neuraxial labor analgesia using the ObsQoR-10 scoring system.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Being ≥18 years old
  • Pregnant women consenting to neuraxial analgesia for labor
  • Being ≥37 weeks gestation

Exclusion

Exclusion Criteria:

  • Patients in whom neuraxial analgesia is contraindicated
  • Being <18 years old
  • Being <37 weeks gestation

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: labor with neuraxial labor analgesia
Phase:
Study Start date:
March 26, 2024
Estimated Completion Date:
August 26, 2024

Study Description

In this study, we planned to conduct a study to compare the postpartum recovery of pregnant women according to patient-reported outcome measures using the ObsQoR-10 score in vaginal deliveries with and without neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia).

In this study, after obtaining the approval of the ethics committee of Atatürk University Faculty of Medicine Hospital and written informed consent of the patients, 40 pregnant women who will deliver vaginally with or without neuraxial analgesia will be prospectively enrolled.

Patients will be randomized by a statistician using a computerized random numbers table and divided into 2 equal groups as Group A and Group B. Pregnant women in Group A will receive neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia), while Group B will not. If postpartum analgesic needs arise, patients in Group A will receive 0.0625% bupivacaine via epidural route, while pregnant women in Group B will receive iboprufen and acetaminophen if needed.

ObsQoR-10 scores of the postpartum patients will be evaluated and recorded at discharge. In addition, basic demographic information and medical, analgesic and obstetric parameters related to the peripartum period will be recorded.

Connect with a study center

  • Atatürk University

    Erzurum,
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.